2.25

1.75% -0.04

After Hours: 2.17 -0.08 -3.56%

Sight Sciences Inc (SGHT)

Overview News Price History Option Chain Financials Why SGHT Down? Discussions Forecast

Sight Sciences Inc stock is traded at $2.25, with a volume of 310.27K. It is down -1.75% in the last 24 hours and down -15.09% over the past month. Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

Previous Close:

$2.29

Open:

$2.22

24h Volume:

310.27K

Relative Volume:

1.24

Market Cap:

$117.55M

Revenue:

$81.06M

Net Income/Loss:

$-55.55M

P/E Ratio:

-1.9737

EPS:

-1.14

Net Cash Flow:

$-47.98M

1W Performance:

-15.89%

1M Performance:

-15.09%

6M Performance:

-63.59%

1Y Performance:

-58.64%

1-Day Range:

$2.19

$2.54

1-Week Range:

$2.19

$2.785

52-Week Range:

$2.17

$8.45

Sight Sciences Inc Stock (SGHT) Company Profile

Name

Sight Sciences Inc

Sector

Healthcare (1183)

Industry

Medical Devices (160)

Phone

(415) 889-0550

Address

4040 CAMPBELL AVE,, MENLO PARK

Employee

216

Twitter

Next Earnings Date

2025-03-05

Latest SEC Filings

SGHT's Discussions on Twitter

Compare SGHT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SGHT Sight Sciences Inc	2.25	117.55M	81.06M	-55.55M	-47.98M	-1.14
ABT Abbott Laboratories	131.93	228.81B	41.95B	13.40B	6.35B	7.65
BSX Boston Scientific Corp	100.05	149.74B	16.75B	1.85B	2.37B	1.25
SYK Stryker Corp	377.46	142.48B	22.60B	2.99B	3.49B	7.76
MDT Medtronic Plc	88.86	113.49B	33.20B	4.26B	5.47B	3.29
EW Edwards Lifesciences Corp	72.05	42.10B	5.72B	4.17B	259.90M	6.97

Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-06-24	Initiated	UBS	Buy
Nov-04-24	Downgrade	Lake Street	Buy → Hold
Aug-21-24	Initiated	Lake Street	Buy
Sep-12-23	Downgrade	BofA Securities	Neutral → Underperform
Sep-12-23	Downgrade	Piper Sandler	Overweight → Neutral
Sep-12-23	Downgrade	William Blair	Outperform → Mkt Perform
Aug-24-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jul-10-23	Downgrade	Citigroup	Buy → Neutral
Jan-06-23	Upgrade	Stifel	Hold → Buy
Oct-04-22	Initiated	Needham	Hold
Jul-26-22	Initiated	Stifel	Hold
Feb-03-22	Initiated	William Blair	Outperform
Jan-07-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight

View All

Sight Sciences Inc Stock (SGHT) Latest News

Mar 31, 2025

Charles Schwab Investment Management Inc. Raises Stock Position in Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World

Mar 31, 2025

Mar 30, 2025

Sight Sciences, Inc. (NASDAQ:SGHT) Looks Inexpensive But Perhaps Not Attractive Enough - simplywall.st

Mar 30, 2025

Mar 29, 2025

Sight sciences chief legal officer sells shares worth $19,250 - MSN

Mar 29, 2025

Mar 26, 2025

Sight Sciences to Present at the 24th Annual Needham Healthcare Conference on April 8th - GlobeNewswire

Mar 26, 2025

Mar 25, 2025

Key Investor Updates Coming: Sight Sciences Takes Center Stage at Major Healthcare Conference - Stock Titan

Mar 25, 2025

RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference - The Manila Times

Mar 25, 2025

Mar 16, 2025

Sight Sciences, Inc. (NASDAQ:SGHT) Receives Average Recommendation of “Hold” from Analysts - Defense World

Mar 16, 2025

Mar 15, 2025

Sight sciences EVP Manohar Raheja buys $53,250 in stock By Investing.com - Investing.com Australia

Mar 15, 2025

Mar 13, 2025

Sight sciences EVP Manohar Raheja buys $53,250 in stock - Investing.com India

Mar 13, 2025

Mar 09, 2025

Lake Street Capital Cuts Sight Sciences (NASDAQ:SGHT) Price Target to $2.50 - The AM Reporter

Mar 09, 2025

Sight Sciences’ (SGHT) Hold Rating Reiterated at Needham & Company LLC - Defense World

Mar 09, 2025

Piper Sandler Cuts Sight Sciences (NASDAQ:SGHT) Price Target to $3.50 - Defense World

Mar 09, 2025

Mar 08, 2025

Compared to Estimates, Sight Sciences (SGHT) Q4 Earnings: A Look at Key Metrics - MSN

Mar 08, 2025

Lake Street Capital Has Lowered Expectations for Sight Sciences (NASDAQ:SGHT) Stock Price - Defense World

Mar 08, 2025

Stifel Nicolaus Has Lowered Expectations for Sight Sciences (NASDAQ:SGHT) Stock Price - Defense World

Mar 08, 2025

Earnings call transcript: Sight Sciences Q4 2024 results miss forecasts By Investing.com - Investing.com Australia

Mar 08, 2025

Mar 07, 2025

Actinic Keratosis Market Forecast 2034: EMA, PDMA, FDA Approvals, Prevalence, Clinical Trials, Treatment, Medication, Therapies, and Companies by DelveInsight - The Globe and Mail

Mar 07, 2025